Journal of Cardiopulmonary Rehabilitation and Prevention,
Journal Year:
2024,
Volume and Issue:
44(6), P. 409 - 416
Published: Oct. 31, 2024
The
Coronavirus
Disease
2019
(COVID-19)
pandemic
had
a
major
global
impact
on
health
care,
including
the
delivery,
modality,
and
importance
of
outcomes
in
pulmonary
rehabilitation
(PR).
This
review
discusses
PR
changes
that
were
required
to
maintain
its
delivery.
article
reviews
current
evidence
during
COVID-19
period,
focusing
delivery
models,
modalities,
outcomes,
perspectives,
barriers.
A
search
MEDLINE,
Embase,
SciELO
databases
Cochrane
Library
this
topic
was
conducted
between
December
1,
August
2023.
Studies
reviewed
relevant
topics
included
narrative.
Rehabilitation
patients
with
severe
acute
symptoms
long
COVID
has
been
challenging.
number
programs
worldwide
is
still
low,
community-based
are
rare.
Integrated
multidisciplinary
approach
exercise
therapy
individualized
prescription
based
have
an
interesting
strategy.
Telerehabilitation
outpatient
both
effective
treatment
chronic
obstructive
disease.
However,
uptake
remains
considerably
technological
barriers
for
lack
resources
low-income
countries
affect
these
services
much
world.
Sports Medicine - Open,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: April 24, 2024
Abstract
People
with
long
COVID
may
suffer
from
a
wide
range
of
ongoing
symptoms
including
fatigue,
exertional
dyspnea,
reduced
exercise
performance,
and
others.
In
particular,
impaired
performance
is
condition
that
can
be
recovered
in
many
people
through
an
individualized
physical
training
program.
However,
clinical
experience
has
shown
the
presence
post-exertional
malaise
(PEM)
significant
barrier
to
COVID.
Currently,
there
no
guideline
or
consensus
available
on
how
apply
this
cohort.
Therefore,
we
conducted
literature
review
PubMed
library
using
following
search
terms:
“COVID”,
“post-COVID”,
“long
COVID”
“exercise”
searching
for
studies
January
2020
2024.
Data
46
trials
were
included.
Exercise
regimes
very
heterogeneous
none
these
reported
management
PEM
context
Based
feedback
additional
survey
was
answered
by
14
international
experts
field
COVID,
combined
authors´
own
extensive
practical
experience,
best
practice
proposal
recommendations
been
developed.
This
differentiates
procedures
according
no,
mild/moderate
severe
These
guide
allied
healthcare
professionals
worldwide
initiating
adjusting
programs
stratified
severity
PEM.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(1), P. 213 - 213
Published: Jan. 2, 2025
Acute
cardiovascular
disorders
are
incriminated
in
up
to
33%
of
maternal
deaths,
and
the
presence
sickle
cell
anemia
(SCA)
aggravates
risk
peripartum
complications.
Herein,
we
present
a
24-year-old
Caribbean
woman
with
known
SCA
who
developed
vaso-occlusive
crisis
at
36
weeks
gestation
that
required
emergency
Cesarean
section.
In
early
postpartum
period,
she
experienced
fever
rapid
onset
acute
respiratory
distress
context
COVID-19
infection
tracheal
intubation
mechanical
ventilatory
support
broad-spectrum
antibiotics
blood
exchange
transfusion.
Shortly
thereafter,
transthoracic
echocardiography
documented
severe
biventricular
dysfunction
associated
raising
levels
cardiac
troponin
ECG
signs
myocardial
ischemia.
Medical
treatment
incremental
dobutamine
noradrenaline
infusion
failed
improve
output
gas
exchange.
After
consultation
regional
center,
prompt
decision
was
made
provide
via
implantation
femoral
cannula
initiation
veno-arterial
extracorporeal
membrane
oxygenation
(ECMO,
Cardiohelp®).
Under
stable
ECMO,
patient
transferred
by
helicopter
specialized
center.
There
were
no
ongoing
hemolysis,
progressive
recovery
right
left
ventricular
function
facilitated
forward
flow
through
aortic
valve.
Three
days
after
implantation,
ECMO
weaned,
removed.
One
day
later,
patient’s
chest
X-rays
showed
partial
resolution
lung
edema.
The
successfully
extubated,
non-invasive
ventilation
pulmonary
rehabilitation
initiated
speed
her
functional
recovery.
Therapeutic Advances in Respiratory Disease,
Journal Year:
2025,
Volume and Issue:
19
Published: Jan. 1, 2025
Background:
Pulmonary
rehabilitation
(PR)
has
demonstrated
efficacy
in
managing
long
COVID-19,
underscoring
the
need
to
refine
and
tailor
PR
strategies
for
optimal
patient
outcomes.
Objectives:
To
evaluate
impact
of
on
patients
with
COVID-19
compare
different
types
durations
interventions.
Design:
Systematic
review
meta-analysis.
Data
sources
methods:
We
systematically
searched
randomized
controlled
trials
(RCTs)
effectiveness
published
before
April
2024.
The
primary
outcomes
were
physical
capacity
assessed
by
6-minute
walking
test
(6MWT),
lung
function
measured
forced
expiratory
volume
first
second
(FEV1)
vital
(FVC),
health-related
quality
life
(HRQoL),
fatigue.
Secondary
thirty-second
sit-to-stand
(30STST),
handgrip
strength
tests,
maximal
inspiratory
pressure
(MIP),
(MEP),
dyspnea,
depression,
anxiety,
perceived
effort,
adverse
events.
Results:
A
total
37
studies
3363
included.
Compared
controls,
improved
(6MWT,
30STST,
handgrip),
(FEV1,
FVC,
MIP,
MEP),
HRQoL,
fatigue,
anxiety
but
did
not
reach
statistical
significance
depression.
Subgroup
analyses
duration
indicated
that
programs
⩽4
weeks
6MWT;
those
between
4
8
significantly
6MWT,
FVC),
reduced
fatigue;
over
HRQoL
Exercise
type
analysis
revealed
breathing
exercises
HRQoL;
multicomponent
enhanced
6MWT
performance
combination
both
FEV1
(L),
FVC
(%pred),
Conclusion:
improves
capacity,
function,
alleviates
patients.
4-
8-week
program
a
breath
training
is
most
effective
long-term
syndromes.
Trial
registration:
PROSPERO
ID:
CRD42024455008.
Reports — Medical Cases Images and Videos,
Journal Year:
2025,
Volume and Issue:
8(1), P. 35 - 35
Published: March 20, 2025
Background:
Post
COVID-19
Condition
is
a
recently
recognized
syndrome
characterized
by
the
persistence
of
various
symptoms,
including
dyspnea,
physical
and
mental
fatigue,
post-exertional
malaise.
Currently,
there
no
established
treatment
or
clear
consensus
on
effectiveness
rehabilitation,
given
that
patients
could
benefit
from
home-based
telerehabilitation,
defined
as
remote
rehabilitation
using
telematic
systems,
may
be
an
option
to
reach
more
population
with
persistent
symptoms.
Therefore,
it
necessary
show
efficacy
this
approach
benefits
multimodal
strategy
in
these
patients.
Methods:
Patients
underwent
home
12-week
synchronous
telerehabilitation
system.
The
intervention
included
therapeutic
education
respiratory
rehabilitation.
following
variables
were
analyzed:
Fatigue,
quality
life,
strength,
aerobic
capacity,
upper
lower
limb
strength.
Conclusions:
After
12
weeks,
significant
improvements
found
However,
improvement
was
dyspnea
scores,
which
did
not
correlate
Interestingly,
post-intervention
correlation
emerged
between
distance
covered
capacity
perceived
suggesting
asynchronous
viable
for
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(4), P. e0321811 - e0321811
Published: April 29, 2025
Background
It
is
estimated
that
at
least
10%
of
the
population
infected
with
SARS-CoV-2
develop
Post
COVID
Condition,
which
characterized
by
a
diverse
array
symptoms
including
dyspnea,
fatigue,
anxiety,
depression,
and
deterioration
in
quality
life.
The
virus
can
trigger
an
excessive
immune
response,
release
pro-inflammatory
cytokines
IL-6,
IL-1,
TNFα
reactive
oxygen
species.
Specialized
Pro
Resolving
Mediators
(SPMs)
(17-HAD,
14-HAD
18_HEPE)
could
be
useful
Condition
modulating
inflammatory
response.
objective
to
determine
change
life,
profile,
functional
capacity
emotional
variables
group
taking
nutritional
supplement
plus
telerehabilitation
programme.
Methods
ARACOV-2
study
double-blind,
parallel-group,
randomized
control
trial
two
parallel
interventions:
Nutritional
vs
placebo
telerehabilitation.
primary
endpoint
will
life
(EQ-5L-5D).
intervention
last
12
weeks
daily
intake
omega-3
or
supervised
rehabilitation
programme
using
Discussion
This
suggests
SPMs
supplementation
combined
may
improve
inflammation
like
fatigue
patients.
Both
interventions
have
anti-inflammatory
potential,
their
use
enhance
physical
mental
health
outcomes.
approach
offers
promising
strategy
for
managing
symptoms.
Trial
registration
ClinicalTrials.gov
NCT06063031
BMJ Open,
Journal Year:
2024,
Volume and Issue:
14(7), P. e074325 - e074325
Published: July 1, 2024
Objective
To
assess
the
effects
of
telerehabilitation
on
clinical
symptoms,
physical
function,
psychological
function
and
quality
life
(QoL)
in
patients
with
post-COVID-19.
Design
Systematic
review
meta-analysis
randomised
controlled
trials
(RCTs).
Data
sources
PubMed,
Web
Science,
Embase
Cochrane
Library
were
searched
for
publications
from
1
January
2020
to
17
April
2024.
Eligibility
criteria
RCTs
investigating
post-COVID-19
included.
The
outcomes
interest
encompassed
QoL.
Only
studies
reported
English
extraction
synthesis
Two
reviewers
independently
extracted
data
evaluated
risk
bias.
Statistical
analysis
was
conducted
using
Review
Manager
V.5.3,
employing
mean
difference
(MD)
a
95%
CI,
corresponding
P
value
used
ascertain
treatment
effect
between
groups.
Heterogeneity
quantified
I
2
statistic.
evidence
assessed
by
GRADE.
Results
16
(n=1129)
included
this
systematic
review,
15
which
(n=1095,
comparisons)
meta-analysis.
primary
pooled
demonstrated
that,
compared
no
rehabilitation
or
usual
care,
can
improve
(measured
30
s
sit-to-stand
test
[6
RCTs,
n=310,
MD=1.58
stands,
CI
0.50
2.66;
p=0.004];
6
min
walking
distance
n=324,
MD=76.90
m,
49.47
104.33;
p<0.00001];
36-item
short-form
health
survey
[5
n=380,
MD=6.12
units,
2.85
9.38;
p=0.0002]).
However,
results
did
not
indicate
significant
improvements
pulmonary
graded
as
low
Hospital
Anxiety
Depression
Scale-anxiety
very
other
outcomes.
overall
completion
rate
78.26%,
reports
severe
adverse
events
any
trials.
Conclusions
Despite
lack
certain
variables,
could
be
an
effective
safe
option
enhancing
It
is
advisable
conduct
further
well-designed
continue
in-depth
exploration
topic.
Study
registration
PROSPERO,
CRD42023404647.
Healthcare,
Journal Year:
2024,
Volume and Issue:
12(18), P. 1864 - 1864
Published: Sept. 16, 2024
Background:
Several
studies
have
shown
that
pulmonary
telerehabilitation
(PTR)
improves
respiratory
capacity.
However,
there
is
little
evidence
of
its
effectiveness
in
youth
with
post-COVID-19
conditions
(PCC).
This
study
analyzed
the
effects
a
PTR
program
on
young
adults
PCC.
Methods:
Sixteen
youths
were
randomly
assigned
to
control
group
(CG)
or
an
experimental
(EG),
eight
participants
each.
The
EG
participated
included
twelve
remote,
asynchronous
four-week
sessions
diaphragmatic
breathing
and
aerobic
exercises.
Vital
signs
(SpO2,
HR,
RR,
BP),
physical
capacity
(sit-to-stand
test),
cardiorespiratory
(6-Minute
Walk
Test),
perceived
exertion
(Borg
scale)
assessed
both
groups.
Results:
Statistical
analyses
showed
significant
decrease
RR
HR
(p
<
0.012)
increase
SpO2
0.042),
0.012),
0.028)
Perceived
effort
decreased
significantly
groups
(CG:
p
0.006;
EG:
0.001)
only
for
but
not
0.106).
There
no
statistical
changes
registered
BP
>
0.05).
Conclusions:
program,
which
includes
exercises,
feasible
effective
improving
people
PCC,
as
well
reducing
dyspnea.